Prescription Alerts for Reliever inhalers in Children (PARC) project

Not Applicable

• Conditions: Paediatric asthma; Respiratory

• Registration Number: ISRCTN12460754
• Lead Sponsor: niversity Hospital Southampton NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-04
• Last Update Posted: 5 August 2024
• Study Completion: 2027-01-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 614

Inclusion Criteria

1. Children aged 1-17 years old
2. 7 or more prescriptions of SABA inhalers e.g. salbutamol during the qualifying period (previous 12 months for the intervention group, 24-12 months previously for the control group)
3. Informed consent from parent/guardian/participant with assent from participant where appropriate

(Children do not need to have a recorded diagnosis of asthma to be eligible to participate in the project)

Exclusion Criteria

1. Other (in addition to asthma) long-term respiratory condition e.g. cystic fibrosis.
2. Enrolled in another interventional research study.
3. Participant or parent/guardian unable to communicate sufficiently (with an interpreter where available) to complete consent forms and have an asthma review.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of severe asthma attacks measured using data collected from medical records during the 12 months following the asthma review (intervention group), or during the 12 months before the asthma review (control group)